<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0365-0596</journal-id>
<journal-title><![CDATA[Anais Brasileiros de Dermatologia]]></journal-title>
<abbrev-journal-title><![CDATA[An. Bras. Dermatol.]]></abbrev-journal-title>
<issn>0365-0596</issn>
<publisher>
<publisher-name><![CDATA[Sociedade Brasileira de Dermatologia]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0365-05962006000200004</article-id>
<article-id pub-id-type="doi">10.1590/S0365-05962006000200004</article-id>
<title-group>
<article-title xml:lang="pt"><![CDATA[Carcinoma basocelular - Análise de 300 casos observados em Uberlândia - MG]]></article-title>
<article-title xml:lang="en"><![CDATA[Basal cell Carcinoma - Analysis of 300 cases observed in Uberlândia - MG, Brazil]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Mantese]]></surname>
<given-names><![CDATA[Sônia Antunes Oliveira]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Berbert]]></surname>
<given-names><![CDATA[Alceu Luiz Camargo V.]]></given-names>
</name>
<xref ref-type="aff" rid="A02"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Gomides]]></surname>
<given-names><![CDATA[Mabel Duarte Alves]]></given-names>
</name>
<xref ref-type="aff" rid="A03"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rocha]]></surname>
<given-names><![CDATA[Ademir]]></given-names>
</name>
<xref ref-type="aff" rid="A04"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,Universidade Federal de Uberlândia Professora-adjunto IV de Dermatologia]]></institution>
<addr-line><![CDATA[Uberlândia MG]]></addr-line>
<country>Brasil</country>
</aff>
<aff id="A02">
<institution><![CDATA[,Universidade Federal de Uberlândia Professor-assistente de Dermatologia ]]></institution>
<addr-line><![CDATA[Uberlândia MG]]></addr-line>
<country>Brasil</country>
</aff>
<aff id="A03">
<institution><![CDATA[,Universidade Federal de Uberlândia Médica dermatologista ]]></institution>
<addr-line><![CDATA[Uberlândia MG]]></addr-line>
<country>Brasil</country>
</aff>
<aff id="A04">
<institution><![CDATA[,Universidade Federal de Uberlândia Professor titular de Anatomia Patológica ]]></institution>
<addr-line><![CDATA[Uberlândia MG]]></addr-line>
<country>Brasil</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>03</month>
<year>2006</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>03</month>
<year>2006</year>
</pub-date>
<volume>81</volume>
<numero>2</numero>
<fpage>136</fpage>
<lpage>142</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.br/scielo.php?script=sci_arttext&amp;pid=S0365-05962006000200004&amp;lng=en&amp;nrm=iso&amp;tlng=en"></self-uri><self-uri xlink:href="http://www.scielo.br/scielo.php?script=sci_abstract&amp;pid=S0365-05962006000200004&amp;lng=en&amp;nrm=iso&amp;tlng=en"></self-uri><self-uri xlink:href="http://www.scielo.br/scielo.php?script=sci_pdf&amp;pid=S0365-05962006000200004&amp;lng=en&amp;nrm=iso&amp;tlng=en"></self-uri><abstract abstract-type="short" xml:lang="pt"><p><![CDATA[FUNDAMENTO: O carcinoma basocelular é o câncer da pele mais comum, compreendendo 75% dos tumores epiteliais malignos. Localiza-se na face e acomete indivíduos brancos, acima de 40 anos de idade, com história de exposição repetitiva à luz solar. OBJETIVO: Descrever o carcinoma basocelular em suas variáveis epidemiológica, clínica e histopatológica. CASUÍSTICA: Realizou-se estudo transversal de 300 pacientes com carcinoma basocelular atendidos no Serviço de Dermatologia do Hospital de Clínicas, no período de 1999 a 2003. Foram preenchidos protocolos com identificação do paciente, história de exposição solar e caracterização do carcinoma basocelular. RESULTADOS: Foram identificadas 447 lesões de carcinoma basocelular nos 300 pacientes estudados, cuja maioria era do sexo feminino (59,3%) e da raça branca (93%), com história de exposição solar (90,3%), apresentando lesão única (74%), predominantemente facial (77% das lesões). O tipo histopatológico mais freqüente foi o nodular (46,3% das lesões), com predomínio do superficial no tronco. CONCLUSÕES: Observou-se predomínio do carcinoma basocelular no sexo feminino, demonstrando a tendência atual desse tumor. A presença de vários tumores sucessivos ou simultâneos em um mesmo paciente salienta a importância de exames periódicos nesses doentes. Não se estabeleceu correlação entre os tipos clínicos e histopatológicos. Confirmou-se que o tipo superficial é mais freqüente no tronco.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[BACKGROUND: Basal cell Carcinoma is the most common type of skin cancer and represents 75% of malignant epithelial tumors. It usually occurs on the face of white individuals aged over 40 years, with history of repetitive exposure to sunlight OBJECTIVE: To describe the epidemiological data, clinical presentation and histopathological findings of 300 patients with basal cell carcinoma. CASUISTIC: A cross-sectional study of 300 patients with Basal cell Carcinoma seen at the outpatient Dermatology clinic from 1999 to 2003. Information was obtained on identification, exposure to sunlight and characterization of Basal cell Carcinoma. RESULTS: The pathological examinations confirmed the clinical diagnoses of 447 tumor lesions of 300 patients. Most patients were female (59.3%), white (93%), had exposure to sunlight (90.3%), with a single lesion (74%), involving predominantly the face (77% of the lesions). The most frequent pathological type was nodular carcinoma (46.3% of the lesions) and the superficial type predominated on the trunk. CONCLUSIONS: There was a predominance of female patients showing the current tendency of Basal cell Carcinoma. The presence of several successive or simultaneous tumors in the same patient emphasizes the importance of periodical exams in these patients. No exact correlation between exact clinical and pathological findings was established. The superficial type was confirmed as more frequent on the trunk.]]></p></abstract>
<kwd-group>
<kwd lng="pt"><![CDATA[Carcinoma basocelular]]></kwd>
<kwd lng="pt"><![CDATA[Epidemiologia]]></kwd>
<kwd lng="pt"><![CDATA[Neoplasias cutâneas]]></kwd>
<kwd lng="en"><![CDATA[Basal cell Carcinoma]]></kwd>
<kwd lng="en"><![CDATA[Epidemiology]]></kwd>
<kwd lng="en"><![CDATA[Skin neoplasms]]></kwd>
</kwd-group>
</article-meta>
</front><body><![CDATA[ <p align="right"><font face="Verdana" size="2"><b>INVESTIGA&Ccedil;&Atilde;O CL&Iacute;NICA, EPIDEMIOL&Oacute;GICA, LABORATORIAL E TERAP&Ecirc;UTICA</b></font></p>               <p>&nbsp;</p>               <p><font face="Verdana" size="4"><a name="topo"></a><b>Carcinoma basocelular - An&aacute;lise de 300 casos observados em Uberl&acirc;ndia – MG<a href="#nota"><sup>*</sup></a></b></font></p>               <p>&nbsp;</p>               <p>&nbsp;</p>               <p><font face="Verdana" size="2"><b>S&ocirc;nia Antunes Oliveira Mantese<sup>I</sup>; Alceu Luiz Camargo V. Berbert<sup>II</sup>; Mabel Duarte Alves Gomides<sup>III</sup>; Ademir Rocha<sup>IV</sup></b></font></p>                <p><font face="Verdana" size="2"> <sup>I</sup>Professora-adjunto IV de Dermatologia,    Universidade Federal de Uberl&acirc;ndia – UFU - Uberl&acirc;ndia (MG), Brasil    <br>   <sup>II</sup>Professor-assistente de Dermatologia, Universidade Federal de Uberl&acirc;ndia    – UFU - Uberl&acirc;ndia (MG), Brasil    <br>   <sup>III</sup>M&eacute;dica dermatologista, Universidade Federal de Uberl&acirc;ndia    – UFU - Uberl&acirc;ndia (MG), Brasil. T&iacute;tulo de especialista pela Sociedade    Brasileira de Dermatologia - SBD    <br>   <sup>IV</sup>Professor titular de Anatomia Patol&oacute;gica, Universidade Federal    de Uberl&acirc;ndia – UFU - Uberl&acirc;ndia (MG), Brasil</font></p>               ]]></body>
<body><![CDATA[<p><font face="Verdana" size="2"><a href="#end">Endere&ccedil;o para correspond&ecirc;ncia</a></font></p>               <p>&nbsp;</p>               <p>&nbsp;</p>  <hr size="1" noshade>               <p><font face="Verdana" size="2"><b>RESUMO</b></font></p>               <p><font face="Verdana" size="2"><b>FUNDAMENTO:</b> O carcinoma basocelular &eacute; o c&acirc;ncer da pele mais comum, compreendendo 75&#37; dos tumores epiteliais malignos. Localiza-se na face e acomete indiv&iacute;duos brancos, acima de 40 anos de idade, com hist&oacute;ria de exposi&ccedil;&atilde;o repetitiva &agrave; luz solar.         <br>   <b>OBJETIVO:</b> Descrever o carcinoma basocelular em suas vari&aacute;veis epidemiol&oacute;gica, cl&iacute;nica e histopatol&oacute;gica.        <br>   <b>CASU&Iacute;STICA:</b> Realizou-se estudo transversal de 300 pacientes com carcinoma basocelular atendidos no Servi&ccedil;o de Dermatologia do Hospital de Cl&iacute;nicas, no per&iacute;odo de 1999 a 2003. Foram preenchidos protocolos com identifica&ccedil;&atilde;o do paciente, hist&oacute;ria de exposi&ccedil;&atilde;o solar e caracteriza&ccedil;&atilde;o do carcinoma basocelular.            <br>   <b>RESULTADOS:</b> Foram identificadas 447 les&otilde;es de carcinoma basocelular nos 300 pacientes estudados, cuja maioria era do sexo feminino (59,3&#37;) e da ra&ccedil;a branca (93&#37;), com hist&oacute;ria de exposi&ccedil;&atilde;o solar (90,3&#37;), apresentando les&atilde;o &uacute;nica (74&#37;), predominantemente facial (77&#37; das les&otilde;es). O tipo histopatol&oacute;gico mais freq&uuml;ente foi o nodular (46,3&#37; das les&otilde;es), com predom&iacute;nio do superficial no tronco.          <br>   <b>CONCLUS&Otilde;ES:</b> Observou-se predom&iacute;nio do carcinoma basocelular no sexo feminino, demonstrando a tend&ecirc;ncia atual desse tumor. A presen&ccedil;a de v&aacute;rios tumores sucessivos ou simult&acirc;neos em um mesmo paciente salienta a import&acirc;ncia de exames peri&oacute;dicos nesses doentes. N&atilde;o se estabeleceu correla&ccedil;&atilde;o entre os tipos cl&iacute;nicos e histopatol&oacute;gicos. Confirmou-se que o tipo superficial &eacute; mais freq&uuml;ente no tronco.</font></p>               <p><font face="Verdana" size="2"><b>Palavras-chave:</b> Carcinoma basocelular; Epidemiologia; Neoplasias cut&acirc;neas</font></p>  <hr size="1" noshade>               ]]></body>
<body><![CDATA[<p>&nbsp;</p>               <p>&nbsp;</p>               <p><font face="Verdana" size="3"><b>INTRODU&Ccedil;&Atilde;O</b></font></p>               <p><font face="Verdana" size="2">As neoplasias cut&acirc;neas t&ecirc;m, nas &uacute;ltimas d&eacute;cadas, adquirido especial relev&acirc;ncia devido &agrave; sua crescente incid&ecirc;ncia. Dentre elas, destaca-se o carcinoma basocelular (CBC), correspondendo a cerca de 75&#37; do total dos tumores malignos cut&acirc;neos.<sup>1</sup> O CBC acomete principalmente pacientes do sexo masculino, acima de 40 anos de idade, brancos, com relato de exposi&ccedil;&atilde;o solar repetitiva e, freq&uuml;entemente, localiza-se na face.<sup>2-8</sup> Al&eacute;m do aumento da incid&ecirc;ncia,<sup>2,9-11</sup> o CBC tem demonstrado, nos &uacute;ltimos tempos, altera&ccedil;&otilde;es em sua apresenta&ccedil;&atilde;o, como o comprometimento de &aacute;reas fotoprotegidas<sup>12</sup> e tend&ecirc;ncia a maior ocorr&ecirc;ncia no sexo feminino.<sup>11</sup> </font></p>      <p><font face="Verdana" size="2">O CBC deriva de c&eacute;lulas basais da epiderme e do aparelho folicular. &Eacute; um tumor de baixo grau de malignidade, com capacidade de invas&atilde;o local, destrui&ccedil;&atilde;o tecidual, recidivante e com limitado poder de metastatiza&ccedil;&atilde;o. A taxa de mortalidade &eacute; baixa devido &agrave; precocidade do diagn&oacute;stico do CBC nas &aacute;reas expostas e ao crescimento lento das les&otilde;es.</font></p>      <p><font face="Verdana" size="2">O papel da exposi&ccedil;&atilde;o solar como fator de risco no CBC est&aacute; muito bem definido.<sup>2,4,7,9,13-15</sup> A a&ccedil;&atilde;o dos raios ultravioleta (UV) B produz in&uacute;meros fotoprodutos mutag&ecirc;nicos no DNA, que precisam ser reparados antes da divis&atilde;o celular;<sup>7</sup> caso contr&aacute;rio pode promover a muta&ccedil;&atilde;o no gen PTC, que induz o desenvolvimento do CBC.<sup>16-17</sup></font></p>      <p><font face="Verdana" size="2">Esta pesquisa representa uma contribui&ccedil;&atilde;o ao estudo do CBC, j&aacute; que o assunto &eacute; de grande import&acirc;ncia e s&atilde;o poucos os trabalhos publicados com avalia&ccedil;&atilde;o estat&iacute;stica.</font></p>      <p><font face="Verdana" size="2">O presente estudo tem como objetivo a realiza&ccedil;&atilde;o de uma an&aacute;lise prospectiva dos casos de CBC com resultados estat&iacute;sticos de suas vari&aacute;veis epidemiol&oacute;gica, cl&iacute;nica e histopatol&oacute;gica.</font></p>      <p>&nbsp;</p>               <p><font face="Verdana" size="3"><b>CASU&Iacute;STICA </b></font></p>        ]]></body>
<body><![CDATA[<p><font face="Verdana" size="2"> Foram estudados prospectivamente (estudo observacional transversal) 300 pacientes com CBC atendidos no Servi&ccedil;o de Dermatologia do Hospital de Cl&iacute;nicas da Universidade Federal de Uberl&acirc;ndia (HC/UFU), no per&iacute;odo de mar&ccedil;o de 1999 a julho de 2003.</font></p>      <p><font face="Verdana" size="2">O protocolo incluiu os seguintes dados: identifica&ccedil;&atilde;o do paciente (nome, idade, sexo, cor da pele de acordo com a classifica&ccedil;&atilde;o de Fitzpatrick,<sup>18</sup> naturalidade, proced&ecirc;ncia, ocupa&ccedil;&atilde;o, estado civil), h&aacute;bito de exposi&ccedil;&atilde;o solar e caracteriza&ccedil;&atilde;o do CBC (tempo de in&iacute;cio, tamanho, localiza&ccedil;&atilde;o, tipos cl&iacute;nico e histopatol&oacute;gico).</font></p>      <p><font face="Verdana" size="2">Clinicamente, o CBC foi classificado<sup>19</sup> em p&aacute;pulo-nodular, n&oacute;dulo-ulcerado, superficial, terebrante, vegetante, pigmentado, esclerodermiforme, plano-cicatricial e c&iacute;stico. Para facilitar a an&aacute;lise comparativa, optou-se por agrupar os v&aacute;rios tipos cl&iacute;nicos em quatro principais:<sup>20</sup> n&oacute;dulo-ulcerativo (p&aacute;pulo-nodular, n&oacute;dulo-ulcerado, vegetante, terebrante e c&iacute;stico), pigmentado, fibrosante (plano-cicatricial e esclerodermiforme) e superficial.</font></p>      <p><font face="Verdana" size="2">A confirma&ccedil;&atilde;o da hip&oacute;tese diagn&oacute;stica de CBC deu-se por biopsia ou ex&eacute;rese do(s) tumor(es), com posterior descri&ccedil;&atilde;o dos tipos histopatol&oacute;gicos das amostras, que foi realizada pelo Servi&ccedil;o de Anatomia Patol&oacute;gica do HC/UFU, de acordo com as classifica&ccedil;&otilde;es de Kirkham<sup>20</sup> e de Rippey,<sup>21</sup> confirmando a presen&ccedil;a de 447 CBCs nos 300 pacientes estudados.</font></p>      <p><font face="Verdana" size="2">Tendo esta pesquisa o objetivo de analisar dados epidemiol&oacute;gicos e as apresenta&ccedil;&otilde;es cl&iacute;nicas e histopatol&oacute;gicas do CBC prim&aacute;rio nos pacientes atendidos no HC/UFU, foram exclu&iacute;das as les&otilde;es de CBC recidivado, tumores ligados a outras doen&ccedil;as (s&iacute;ndrome do nevo basocelular, xeroderma pigmentoso e albinismo) e certos fatores de risco para c&acirc;ncer cut&acirc;neo (radiodermite cr&ocirc;nica, &uacute;lceras cr&ocirc;nicas, imunodepress&atilde;o e arsenicismo cr&ocirc;nico).</font></p>      <p><font face="Verdana" size="2"><b>T&eacute;cnicas estat&iacute;sticas</b></font></p>      <p><font face="Verdana" size="2">Para an&aacute;lise estat&iacute;stica dos dados foram utilizados: tabelas, porcentagens, teste qui-quadrado (<font face="Symbol">c</font><sup>2</sup>), teste do sinal (Z), teste U de Mann-Whitney (U) e correla&ccedil;&atilde;o de Pearson (r). Considerou-se n&iacute;vel de signific&acirc;ncia p menor ou igual a 0,05. </font></p>      <p>&nbsp;</p>               <p><font face="Verdana" size="3"><b>RESULTADOS</b></font></p>                <p><font face="Verdana" size="2">A idade dos pacientes variou de 30 a 88 anos, com m&eacute;dia de 64,2 anos (64,8 anos no sexo masculino e 63,7 anos no feminino). A faixa et&aacute;ria mais acometida foi a de 70 a 79 anos (86 pacientes; 28,7&#37;), seguida pela de 50 a 59 anos (64 pacientes; 21,3&#37;), de 60 a 69 anos (63 pacientes; 21&#37;), de 40 a 49 anos (39 pacientes; 13&#37;), de 80 a 89 anos (37 pacientes; 12,3&#37;) e de 30 a 39 anos (11 pacientes; 3,7&#37;).</font></p>      ]]></body>
<body><![CDATA[<p><font face="Verdana" size="2">Dos 300 pacientes, 178 (59,3&#37;) eram do sexo feminino, e 122 (40,7&#37;), do masculino na propor&ccedil;&atilde;o de 1,4:1 e com signific&acirc;ncia estat&iacute;stica (<font face="Symbol">c</font><sup>2</sup> = 10,453;  p &lt; 0,01).</font></p>      <p><font face="Verdana" size="2">A correla&ccedil;&atilde;o entre os sexos e a faixa et&aacute;ria n&atilde;o demonstrou signific&acirc;ncia (<font face="Symbol">c</font><sup>2</sup> = 3,87; p = 0,5682), indicando que essas s&atilde;o vari&aacute;veis independentes.</font></p>        <p><font face="Verdana" size="2">Quanto &agrave; cor, 279 (93&#37;) pacientes eram brancos (fototipos I, II e III), 18 (6&#37;) pardos (fototipos IV e V) e tr&ecirc;s (1&#37;) negros (fototipo VI).</font></p>      <p><font face="Verdana" size="2">Em rela&ccedil;&atilde;o &agrave; proced&ecirc;ncia dos pacientes com CBC, observou-se que 225 (75&#37;) eram da cidade de origem do estudo e 75 (25&#37;) de outras cidades.</font></p>        <p><font face="Verdana" size="2">A proced&ecirc;ncia urbana foi referida por 88&#37; dos pacientes deste estudo, sendo apenas 12&#37; de proced&ecirc;ncia rural. Entretanto, observou-se que 63,7&#37; dos pacientes moraram ou trabalharam na zona rural em algum momento de suas vidas.</font></p>      <p><font face="Verdana" size="2">As ocupa&ccedil;&otilde;es foram bastante diversificadas, sendo as mais comuns: do lar (29,6&#37;), lavrador(a) (16,9&#37;), do lar/lavradora (13,3&#37;), vendedor (5&#37;), comerciante (3,6&#37;), pedreiro (3,3&#37;), motorista (2,6&#37;) e costureira (2,3&#37;).</font></p>      <p><font face="Verdana" size="2">Do total de 300 pacientes com CBC, 271 (90,3&#37;) declararam grande exposi&ccedil;&atilde;o solar no decorrer de suas vidas, principalmente nas atividades di&aacute;rias de trabalho.</font></p>      <p><font face="Verdana" size="2">O per&iacute;odo m&eacute;dio de dura&ccedil;&atilde;o das les&otilde;es, desde o surgimento at&eacute; o diagn&oacute;stico, foi de 37,1 meses, sendo de 36,3 meses para o sexo masculino, com desvio padr&atilde;o de 54,6, e de 37,7 meses para o sexo feminino, com desvio padr&atilde;o de 52,6. As diferen&ccedil;as entre os per&iacute;odos m&eacute;dios de dura&ccedil;&atilde;o das les&otilde;es dos dois sexos n&atilde;o foram estatisticamente significantes (U = 10182.5; p = 0,4203).</font></p>      <p><font face="Verdana" size="2">A &aacute;rea m&eacute;dia dos tumores foi de 4,3mm<sup>2</sup>, sendo que no sexo masculino foi de 5,7mm<sup>2</sup>, com desvio padr&atilde;o de 12,8, e nos pacientes do sexo feminino foi de 2,9mm<sup>2</sup>, com desvio padr&atilde;o de 5,6. A diferen&ccedil;a entre as &aacute;reas m&eacute;dias dos dois sexos foi significante (teste U de Mann-Whitney; p &lt; 0,05).</font></p>        <p><font face="Verdana" size="2">Analisando-se o tamanho das les&otilde;es em rela&ccedil;&atilde;o ao tempo do diagn&oacute;stico, por meio do teste de Pearson, n&atilde;o se observou nenhuma tend&ecirc;ncia de associa&ccedil;&atilde;o entre essas vari&aacute;veis, o que pode ser confirmado pela pequena correla&ccedil;&atilde;o entre tais valores (r = 0,23; p&gt; 0,05).</font></p>      ]]></body>
<body><![CDATA[<p><font face="Verdana" size="2">O diagn&oacute;stico do total de les&otilde;es tumorais ocorreu na primeira consulta do paciente ou durante o per&iacute;odo de quatro anos de coleta do trabalho. Encontraram-se 447 les&otilde;es de CBC nos 300 pacientes estudados; o n&uacute;mero de tumores por paciente variou de um (74&#37; dos pacientes) a oito, e n&atilde;o houve signific&acirc;ncia estat&iacute;stica entre os sexos em rela&ccedil;&atilde;o ao n&uacute;mero de pacientes e ao de les&otilde;es (<font face="Symbol">c</font><sup>2</sup> = 1,026; p = 0,311 e <font face="Symbol">c</font><sup>2</sup> = 3,19; p = 0,074, respectivamente). A m&eacute;dia de les&otilde;es por paciente foi de 1,5; a diferen&ccedil;a entre os n&uacute;meros m&eacute;dios de tumores dos pacientes de um sexo e de outro n&atilde;o foi estatisticamente significante (Z = 1,102; p = 0,2585).</font></p>      <p><font face="Verdana" size="2">Quanto &agrave; localiza&ccedil;&atilde;o, as les&otilde;es tumorais foram observadas na cabe&ccedil;a (344 les&otilde;es; 77&#37;), no tronco (53 les&otilde;es; 11,8&#37;), nos membros (34 les&otilde;es; 7,6&#37;) e na regi&atilde;o cervical (16 les&otilde;es; 3,6&#37;). As les&otilde;es da regi&atilde;o cef&aacute;lica predominaram sobre as demais (<font face="Symbol">c</font><sup>2</sup> = 649.7; p &lt; 0,01); houve correla&ccedil;&atilde;o de local e sexo (p &lt; 0,05), sendo maior a ocorr&ecirc;ncia de CBC na regi&atilde;o cef&aacute;lica no sexo feminino, e no tronco e cervical no sexo masculino.</font></p>      <p><font face="Verdana" size="2">Na cabe&ccedil;a, em ordem decrescente de freq&uuml;&ecirc;ncia, as les&otilde;es tumorais apresentaram-se nas seguintes localiza&ccedil;&otilde;es: nasal (26&#37;), malar/zigom&aacute;tica (18,1&#37;), frontal (10,1&#37;), auricular (8,5&#37;), bucinadora (5,8&#37;), orbit&aacute;ria (4,7&#37;), couro cabeludo (2,5&#37;) e mandibular (1,3&#37;). O teste qui-quadrado mostrou depend&ecirc;ncia significante (<font face="Symbol">c</font><sup>2</sup> = 16,39; p &lt; 0,05) entre as vari&aacute;veis local da les&atilde;o na regi&atilde;o cef&aacute;lica e sexo dos pacientes.</font></p>      <p><font face="Verdana" size="2">No tocante ao tipo cl&iacute;nico do CBC, o predominante foi o n&oacute;dulo-ulcerativo, com 297 les&otilde;es (66,5&#37;; <font face="Symbol">c</font><sup>2</sup> = 406,55; p &lt; 0,01), seguido pelos tipos pigmentado com 61 (13,6&#37;), fibrosante com 56 (12,5&#37;) e superficial com 33 (7,4&#37;).</font></p>      <p><font face="Verdana" size="2">Os tipos cl&iacute;nicos dos carcinomas foram    distribu&iacute;dos de acordo com a regi&atilde;o do corpo acometida (<a href="/img/revistas/abd/v81n2/a4tab01.gif">Tabela    1</a>); essa distribui&ccedil;&atilde;o foi independente do local do tumor (<font face="Symbol">c</font><sup>2</sup>    = 9,55; p= 0,374).</font></p>      <p><font face="Verdana" size="2">Os tipos histopatol&oacute;gicos de CBC foram inicialmente distribu&iacute;dos conforme a classifica&ccedil;&atilde;o de Kirkham,<sup>21</sup> com as seguintes freq&uuml;&ecirc;ncias: s&oacute;lido (39,8&#37;), misto (37,1&#37;), fibrosante (8,7&#37;), superficial (7,8&#37;), aden&oacute;ide (5,1&#37;), c&iacute;stico (0,7&#37;), cerat&oacute;sico (0,2&#37;), basoescamoso (0,2&#37;) e c&eacute;lulas claras (0,2&#37;). O tipo chamado misto corresponde &agrave;s observa&ccedil;&otilde;es, num mesmo caso, de dois ou mais padr&otilde;es histol&oacute;gicos (por exemplo, s&oacute;lido e aden&oacute;ide), sem predom&iacute;nio de um sobre o(s) outro(s). A an&aacute;lise estat&iacute;stica entre tipo histopatol&oacute;gico e sexo n&atilde;o mostrou correla&ccedil;&atilde;o significante (<font face="Symbol">c</font><sup>2</sup> = 4,52; p = 0,2104).</font></p>      <p><font face="Verdana" size="2">Para melhor compara&ccedil;&atilde;o com a literatura utilizou-se a proposta resumida de Rippey,<sup>20</sup> classificando os tipos histopatol&oacute;gicos em nodular (46,3&#37;), misto (37,1&#37;), infiltrativo, incluindo esclerodermiforme (8,7&#37;) e superficial (7,8&#37;). Essas diferen&ccedil;as entre os tipos histopatol&oacute;gicos foram estatisticamente significantes (<font face="Symbol">c</font><sup>2</sup> = 206,88;  p &lt; 0,01).</font></p>      <p><font face="Verdana" size="2">Os tipos cl&iacute;nicos foram correlacionados    aos tipos histopatol&oacute;gicos (<a href="/img/revistas/abd/v81n2/a4tab02.gif">Tabela    2</a>). A distribui&ccedil;&atilde;o de um determinado tipo histopatol&oacute;gico    n&atilde;o foi a mesma para todos os tipos cl&iacute;nicos (<font face="Symbol">c</font><sup>2</sup>    = 19,93; p &lt; 0,05).</font></p>      <p><font face="Verdana" size="2">Os tipos histopatol&oacute;gicos dos tumores    foram correlacionados &agrave;s regi&otilde;es afetadas (<a href="/img/revistas/abd/v81n2/a4tab03.gif">Tabela    3</a>), demonstrando elevada depend&ecirc;ncia (<font face="Symbol">c</font><sup>2</sup>    = 24,1397; p &lt; 0,01). Observou-se que o tipo nodular preponderou na regi&atilde;o    cervical (62,5&#37;), tendo ocorrido na cabe&ccedil;a em 47,3&#37;, no tronco    em 39,6&#37; e nos membros em 35,3&#37; dos casos. O tipo superficial apresentou    freq&uuml;&ecirc;ncia elevada (20,7&#37;) no tronco. </font></p>      <p>&nbsp;</p>               ]]></body>
<body><![CDATA[<p><font face="Verdana" size="3"><b>DISCUSS&Atilde;O</b></font></p>                <p><font face="Verdana" size="2">As idades dos pacientes desta pesquisa variaram de 30 a 88 anos, com m&eacute;dia de 64,2 anos, concordando com dados similares encontrados por outros autores.<sup>1,3-6,11,14-17,19,21,22</sup> A faixa et&aacute;ria de maior comprometimento do CBC foi a de 70 a 79 anos, achado semelhante aos de Bastiaens et al.<sup>3</sup> Tem-se ressaltado o crescente aparecimento do CBC na popula&ccedil;&atilde;o jovem;<sup>8,11</sup> entretanto, a m&eacute;dia de idade ainda permanece elevada, sendo provavelmente explicada pela a&ccedil;&atilde;o cumulativa da radia&ccedil;&atilde;o ultravioleta ao longo da vida e pela redu&ccedil;&atilde;o da camada de oz&ocirc;nio.<sup>4,7,8</sup></font></p>        <p><font face="Verdana" size="2">Observou-se neste estudo maior ocorr&ecirc;ncia do CBC no sexo feminino. Esse achado poderia ser, ao menos parcialmente, explicado pelo fato de a popula&ccedil;&atilde;o feminina constituir o p&uacute;blico-alvo de v&aacute;rias campanhas educacionais contra o c&acirc;ncer, tornando as mulheres mais conscientes e atentas ao pr&oacute;prio corpo.</font></p>      <p><font face="Verdana" size="2">Na literatura pesquisada, a maioria dos autores observou maior incid&ecirc;ncia de CBC nos pacientes do sexo masculino.<sup>2,3,5,9,22,23</sup> Prado,<sup>14</sup> Machado Filho et al.<sup>13</sup> e Maffs et al.<sup>5</sup> encontraram predom&iacute;nio no sexo feminino e Dahl et al. (1992)<sup>24</sup> e Betti et al. (1995)<sup>12</sup>  relataram freq&uuml;&ecirc;ncia similar em ambos os sexos. Trabalhos recentes t&ecirc;m apontado discreta tend&ecirc;ncia para o predom&iacute;nio no sexo feminino.<sup>11</sup></font></p>      <p><font face="Verdana" size="2">Nesta pesquisa houve maior freq&uuml;&ecirc;ncia de CBC nos pacientes brancos de fototipos I, II e III,<sup>18</sup> o que est&aacute; de acordo com diversos autores, devido &agrave; suscetibilidade comprovada desses fototipos &agrave; irradia&ccedil;&atilde;o UV.<sup>10,13,15,23</sup></font></p>      <p><font face="Verdana" size="2">Houve predomin&acirc;ncia da proced&ecirc;ncia urbana, apesar de grande parte dos pacientes estudados ter morado ou trabalhado na zona rural durante um per&iacute;odo de suas vidas. Prado<sup>14</sup> relatou maior incid&ecirc;ncia de CBC nos pacientes de zona rural. Machado Filho et al.<sup>13</sup> citaram a origem urbana de todos os seus pacientes.</font></p>      <p><font face="Verdana" size="2">Dos pacientes da presente pesquisa, 90,3&#37; relataram exposi&ccedil;&atilde;o solar no decorrer de suas vidas, principalmente nas atividades di&aacute;rias de trabalho. Cento e trinta e uma mulheres (43,7&#37;) declararam exposi&ccedil;&atilde;o solar freq&uuml;ente, sem prote&ccedil;&atilde;o adequada, enquanto exerciam as atividades do lar. A an&aacute;lise da ocupa&ccedil;&atilde;o dos pacientes demonstrou que 68,1&#37; estavam sujeitos a radia&ccedil;&otilde;es UV repetidas e/ou prolongadas. Alguns autores tamb&eacute;m consideraram a exposi&ccedil;&atilde;o solar prolongada e continuada, relacionada ou n&atilde;o com as atividades profissionais, respons&aacute;vel pela elevada incid&ecirc;ncia de CBC.<sup>3,8,10,11,23</sup> Contrariamente a essa teoria, English et al.<sup>15</sup> n&atilde;o encontraram correla&ccedil;&atilde;o entre CBC e exposi&ccedil;&atilde;o solar di&aacute;ria durante as atividades ocupacionais, diferente do que ocorre com o carcinoma espinocelular. Segundo esses autores, os lavradores sujeitos &agrave; exposi&ccedil;&atilde;o solar prolongada protegiam-se com roupas e chap&eacute;us; enquanto os expositores intermitentes, de final de semana, al&eacute;m de ficar ao sol durante longos per&iacute;odos do dia dispensavam a prote&ccedil;&atilde;o de vestu&aacute;rio adequado, correndo o risco de queimadura solar.</font></p>      <p><font face="Verdana" size="2">O per&iacute;odo m&eacute;dio de dura&ccedil;&atilde;o das les&otilde;es, do surgimento at&eacute; o diagn&oacute;stico, foi de 37,1 meses para ambos os sexos, o que concorda com a id&eacute;ia geral de que o CBC &eacute; um tumor de crescimento lento.</font></p>      <p><font face="Verdana" size="2">A &aacute;rea das les&otilde;es tumorais variou de um a 240mm<sup>2</sup>. A &aacute;rea m&eacute;dia geral foi de 4,3mm<sup>2</sup>, sendo significantemente maior no sexo masculino do que no feminino. Esse dado provavelmente se deve &agrave; procura mais r&aacute;pida de ajuda m&eacute;dica pelas mulheres.</font></p>      <p><font face="Verdana" size="2">Na literatura a &aacute;rea m&eacute;dia tumoral obtida teve a varia&ccedil;&atilde;o de 1,7 a 3,9mm<sup>2</sup>.<sup>5,9</sup> Concordando com Holme et al.,<sup>25</sup> o tamanho reduzido do tumor talvez se deva &agrave; busca precoce de atendimento m&eacute;dico e adequada prepara&ccedil;&atilde;o do profissional da &aacute;rea da sa&uacute;de em identificar les&otilde;es iniciais.</font></p>      ]]></body>
<body><![CDATA[<p><font face="Verdana" size="2">Nesta pesquisa n&atilde;o houve correla&ccedil;&atilde;o entre tempo de evolu&ccedil;&atilde;o e &aacute;rea das les&otilde;es tumorais. Bandeira et al.<sup>11</sup> relataram crescimento lento do CBC nos dois primeiros anos, sendo seu tamanho independente do tempo de evolu&ccedil;&atilde;o.</font></p>      <p><font face="Verdana" size="2">Quanto ao n&uacute;mero de tumores diagnosticados por paciente, observou-se que 26&#37; da amostragem apresentaram les&otilde;es m&uacute;ltiplas, com m&eacute;dia de 1,5 les&atilde;o por paciente. O surgimento de mais de uma les&atilde;o n&atilde;o apresentou correla&ccedil;&atilde;o com sexo; entretanto, sugere estar relacionado com fatores ambientais e/ou &agrave; predisposi&ccedil;&atilde;o gen&eacute;tica. Nos trabalhos analisados a m&eacute;dia geral de tumores por paciente variou de 1,3 a 1,7; e os percentuais de pacientes com mais de uma les&atilde;o variaram de 6,6 a 32&#37;.<sup>2,5,9</sup> A possibilidade acumulada em tr&ecirc;s anos de um paciente com diagn&oacute;stico pr&eacute;vio de CBC apresentar outro basalioma &eacute; de 44&#37;, ou seja, 10 vezes maior do que na popula&ccedil;&atilde;o geral.<sup>26</sup></font></p>      <p><font face="Verdana" size="2">Na presente pesquisa, houve predom&iacute;nio das les&otilde;es de CBC na regi&atilde;o cef&aacute;lica (p &lt; 0,01), sendo a face respons&aacute;vel por 66&#37; das les&otilde;es; a regi&atilde;o nasal esteve comprometida em 39,3&#37; delas e em 260&#37; do total de les&otilde;es do corpo. Esses resultados refletem, provavelmente, &aacute;reas que recebem maior intensidade de raios solares. Os dados da literatura referem maior freq&uuml;&ecirc;ncia do CBC na face (de 27,5&#37; a 91,1&#37;),<sup>6,14,23</sup> na face e no pesco&ccedil;o (de 30,9&#37; a 80&#37;)<sup>2,7,24</sup> e na regi&atilde;o nasal (de 30,1&#37; a 35,9&#37;).<sup>14,23</sup></font></p>      <p><font face="Verdana" size="2">Os homens e as mulheres deste estudo tiveram predomin&acirc;ncia de suas les&otilde;es tumorais na face; mas, quando se comparou segmento acometido e sexo observou-se que o CBC foi mais freq&uuml;ente no tronco, na regi&atilde;o cervical e no pavilh&atilde;o auricular do sexo masculino. Possivelmente esses achados se devem ao fato de essas regi&otilde;es estarem comumente expostas nos trabalhadores do sexo masculino.<sup>9,27</sup></font></p>      <p><font face="Verdana" size="2">O tipo cl&iacute;nico de CBC mais encontrado nesta pesquisa foi o n&oacute;dulo-ulcerativo (66,5&#37;), concordando com achados de alguns autores (de 53,4&#37; a 70,6&#37;).<sup>2,27</sup></font></p>      <p><font face="Verdana" size="2">Correlacionou-se tipo cl&iacute;nico com localiza&ccedil;&atilde;o dos tumores, observando-se que o segmento cef&aacute;lico predominou em todos os tipos cl&iacute;nicos, com maior freq&uuml;&ecirc;ncia do tipo n&oacute;dulo-ulcerativo. Contudo, an&aacute;lises estat&iacute;sticas demonstraram que o tipo cl&iacute;nico distribui-se independentemente da localiza&ccedil;&atilde;o do tumor.</font></p>      <p><font face="Verdana" size="2">Neste estudo, as an&aacute;lises histopatol&oacute;gicas do CBC demonstraram, pela classifica&ccedil;&atilde;o geral de Kirkham,<sup>21</sup> predom&iacute;nio do tipo s&oacute;lido (39,6&#37;) e, pela classifica&ccedil;&atilde;o resumida de Rippey,<sup>20</sup> do tipo nodular (46,1&#37;), concordando com os dados da literatura, que mostram predom&iacute;nio do tipo s&oacute;lido (de 27,4&#37; a 69,1&#37;) e do nodular (de 40 a 63,8&#37;).<sup>9,11,12,20,27</sup></font></p>      <p><font face="Verdana" size="2">Para um determinado tipo histopatol&oacute;gico analisado n&atilde;o houve diferen&ccedil;a entre os sexos. Scrivener et al.<sup>28</sup> demonstraram que o tipo superficial e o fibrosante foram mais freq&uuml;entes no sexo feminino do que no masculino.</font></p>      <p><font face="Verdana" size="2">Na presente pesquisa, correlacionando os tipos cl&iacute;nicos dos tumores com os tipos histopatol&oacute;gicos observou-se que houve concord&acirc;ncia parcial entre a cl&iacute;nica e a histopatologia, com acerto de 49,1&#37; para o n&oacute;dulo-ulcerativo e 18,1&#37; para o superficial. Rassner et al.<sup>29</sup> afirmaram n&atilde;o existir correla&ccedil;&atilde;o estreita entre morfologia cl&iacute;nica e histopatologia no CBC. Por outro lado, Kopke & Schmidt<sup>30</sup> julgaram importante caracterizar a les&atilde;o tumoral como circunscrita ou difusa, tanto cl&iacute;nica quanto histopatologicamente, a fim de se definir o progn&oacute;stico clinico-cir&uacute;rgico.</font></p>      <p><font face="Verdana" size="2">O tipo chamado misto, ou seja, dois ou mais padr&otilde;es histopatol&oacute;gicos numa mesma les&atilde;o, sem predom&iacute;nio de um sobre o(s) outro(s), foi o segundo tipo mais freq&uuml;ente nesta casu&iacute;stica. Kopke & Schmidt30 salientaram que no CBC comumente se encontram padr&otilde;es histopatol&oacute;gicos distintos numa mesma les&atilde;o.</font></p>      ]]></body>
<body><![CDATA[<p><font face="Verdana" size="2">Observou-se freq&uuml;&ecirc;ncia elevada do tipo superficial no tronco (20,7&#37;), concordando com achados anteriores,<sup>3,27,28</sup> ao serem relacionados os tipos histopatol&oacute;gicos dos tumores aos locais afetados.</font></p>      <p>&nbsp;</p>               <p><font face="Verdana" size="3"><b>CONCLUS&Otilde;ES</b></font></p>         <p><font face="Verdana" size="2">Confirmou-se a maior ocorr&ecirc;ncia do CBC em pacientes brancos e na faixa et&aacute;ria de 70 a 79 anos, provavelmente por efeito cumulativo da radia&ccedil;&atilde;o solar ap&oacute;s longo per&iacute;odo de exposi&ccedil;&atilde;o, uma vez que exerciam suas profiss&otilde;es expostos &agrave;s radia&ccedil;&otilde;es solares.</font></p>       <p><font face="Verdana" size="2">O maior n&uacute;mero de casos de CBC e a menor &aacute;rea m&eacute;dia tumoral ocorreram em pacientes do sexo feminino. Esses fatos ainda n&atilde;o foram elucidados, mas podem ser ao menos parcialmente explicados pela conscientiza&ccedil;&atilde;o da popula&ccedil;&atilde;o feminina em procurar assist&ecirc;ncia m&eacute;dica precocemente.</font></p>       <p><font face="Verdana" size="2">A presen&ccedil;a de mais de uma les&atilde;o tumoral no mesmo paciente foi freq&uuml;ente, justificando a avalia&ccedil;&atilde;o peri&oacute;dica dos doentes com CBC pr&eacute;vio.</font></p>       <p><font face="Verdana" size="2">Demonstrou-se o freq&uuml;ente acometimento da regi&atilde;o cef&aacute;lica, com destaque para o dorso nasal, provavelmente por sua maior exposi&ccedil;&atilde;o &agrave; luz solar. Pacientes do sexo masculino apresentaram predom&iacute;nio do CBC no tronco, na regi&atilde;o cervical e no pavilh&atilde;o auricular, possivelmente pelo fato de essas serem localiza&ccedil;&otilde;es comumente expostas nos homens durante o trabalho ou o lazer e pelo h&aacute;bito de cabelos curtos.</font></p>       <p><font face="Verdana" size="2">Os tipos cl&iacute;nicos e histopatol&oacute;gicos apresentaram grande varia&ccedil;&atilde;o, sendo o n&oacute;dulo-ulcerativo e o nodular os mais freq&uuml;entes. N&atilde;o houve correla&ccedil;&atilde;o de tipo cl&iacute;nico com local de comprometimento e nem com tipo histopatol&oacute;gico. Confirmou-se que o tipo histopatol&oacute;gico superficial &eacute; mais freq&uuml;ente no tronco do que em outras regi&otilde;es do corpo.</font></p>       <p><font face="Verdana" size="2">Estudos posteriores, incluindo aumento da amostra, ser&atilde;o necess&aacute;rios para melhor avalia&ccedil;&atilde;o epidemiol&oacute;gica e cl&iacute;nico-histopatol&oacute;gica do CBC.</font></p>             <p>&nbsp;</p>            ]]></body>
<body><![CDATA[<p><font face="Verdana" size="3"><b>REFER&Ecirc;NCIAS</b></font></p>                <!-- ref --><p><font face="Verdana" size="2">1. Carucci JA, Leffell DJ. Basal cell carcinoma. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, editors. Fitzpatrick’s dermatology in general medicine. USA: McGraw-Hill; 2003. p.747-54.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000094&pid=S0365-0596200600020000400001&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana" size="2">2. Naldi L, Dilandro A, D’Avanzo B, Parazzini F. Oncology cooperative group of the Italian group for epidemiological research in dermatology. Host-related and environmental risk factors for cutaneous basal cell carcinoma: Evidence from an Italian case-control study. J Am Acad Dermatol. 2000;42:446-52.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000095&pid=S0365-0596200600020000400002&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana" size="2">3. Bastiaens MT, Hoefnagel JJ, Bruijn JA, Westendorp RGJ, Bavinck VNB, Bavinck JNB. Differences in age, site distribution, and sex between nodular and superficial basal cell carcinomas indicate different types of tumors. J Invest Dermatol. 1998;110:880-4.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000096&pid=S0365-0596200600020000400003&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana" size="2">4. Katz M.H. Nonmelanoma skin cancer. Maryl Med J. 1997;46:238-42.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000097&pid=S0365-0596200600020000400004&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana" size="2">5. Maafs E, De La Barreda F, Delgado R, Mohar A, Alfeir&aacute;n A. Basal cell carcinoma of trunk and extremities. Int J Dermatol. 1997;36:622-8.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000098&pid=S0365-0596200600020000400005&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana" size="2">6. Franceschi S, Levi F, Randimbison L, La Vecchia C. Site distribution of different types of skin cancer: new aetiological clues. Int J Cancer. 1996;67:24-8.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000099&pid=S0365-0596200600020000400006&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana" size="2">7. Corona R. Epidemiology of nonmelanoma skin cancer: review. Ann Ist Super Sanit&agrave;. 1996;32:37-42. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000100&pid=S0365-0596200600020000400007&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana" size="2">8. Green A, Battistutta D, Hart V, Leslie D, Weedon D,  Nambour Study Group. Skin cancer in a subtropical Australian population: incidence and lack of association with occupation. Am J Epidemiol. 1996;144:1034-40.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000101&pid=S0365-0596200600020000400008&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana" size="2">9. Castro LGM, Toyana CL, Gomes AP, Freire MA, Britto TF. C&acirc;ncer de pele em cl&iacute;nica particular em S&atilde;o Paulo – SP. An Bras Dermatol. 1996;71:471-6.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000102&pid=S0365-0596200600020000400009&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana" size="2">10. Maia M, Proen&ccedil;a NG, Moraes JC. Risk factors for basal cell carcinoma: a case-control study. Rev Saude Publica. 1995;29:27-37.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000103&pid=S0365-0596200600020000400010&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana" size="2">11. Bandeira AM, Bandeira V, Silva JF, Mazza E. Carcinoma basocelular: estudo cl&iacute;nico e anatomopatol&oacute;gico de 704 tumores. An Bras Dermatol. 2003;78:23-34.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000104&pid=S0365-0596200600020000400011&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana" size="2">12. Betti R, Inselvini E, Carducci M, Crosti C. Age and site prevalence of histologic subtypes of basal cell carcinomas.  Int J Dermatol. 1995;34:174-6.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000105&pid=S0365-0596200600020000400012&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana" size="2">13. Machado Filho CDA, Fagundes DS, Sender F, Saraiva GL, Paschoal LHC, Costa MCC, et al. Neoplasias malignas cut&acirc;neas: estudo epidemiol&oacute;gico. An Bras Dermatol. 1996;71:479-84.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000106&pid=S0365-0596200600020000400013&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana" size="2">14. Prado H. Carcinoma basocelular. An Bras Dermatol. 1987;62:143-6.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000107&pid=S0365-0596200600020000400014&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana" size="2">15. English DR, Armstrong BK, Kricker A, Fleming C. Sunlight and cancer. Cancer Causes Control. 1997;8:271-83.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000108&pid=S0365-0596200600020000400015&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana" size="2">16. Saldanha G. The Hedgehog  signaling pathway and cancer. J Pathol. 2001;193:427-32.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000109&pid=S0365-0596200600020000400016&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana" size="2">17. Bale AE, Yu K. The Hedgehog pathway and basal cell carcinomas. Hum Mol Genet. 2001;10:757-62.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000110&pid=S0365-0596200600020000400017&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana" size="2">18. Fitzpatrick TB. The validity and practicality of sun reactive skin types I-VI. Arch  Dermatol. 1988;124:869-71.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000111&pid=S0365-0596200600020000400018&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana" size="2">19. Odom RB, James WD, Berger TG. Andrew’s diseases of the skin: clinical dermatology. 9th ed. Philadelphia: W.B. Saunders; 2000. p.800-68.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000112&pid=S0365-0596200600020000400019&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana" size="2">20. Rippey JJ. Why classify basal cell carcinomas? Histopathology. 1998;32:393-8.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000113&pid=S0365-0596200600020000400020&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana" size="2">21. Kirkham N. Tumors and cysts of the epidermis. In: Elder D, Elenitsas R, Jaworsky C, Johnson Jr, editors. B. Lever’s histopathology of the skin. USA: Philadelphia; 1997. p.685-746.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000114&pid=S0365-0596200600020000400021&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana" size="2">22. McKie RM. Epidermal skin tumors. In: Champion RH, Burton JL, Burns DA, Breathnach SM, editors. Rook/Wilkinson/Ebling: textbook of dermatology. London: Blackwell Science; 2004. p.1651-93.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000115&pid=S0365-0596200600020000400022&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana" size="2">23. Minelli L. Estudo estat&iacute;stico do carcinoma basocelular em Londrina, Paran&aacute;, Brasil. An Bras Dermatol. 1987;62:321-5.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000116&pid=S0365-0596200600020000400023&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana" size="2">24. Dahl E, Aberg M, Rausing A, Rausing EL. Basal cell carcinoma. Cancer. 1992;70:104-8.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000117&pid=S0365-0596200600020000400024&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana" size="2">25. Holme AS, Malinovszky K, Roberts DL. Changing trends in non-melanoma skin cancer in South Wales, 1988-98. Br J Dermatol. 2000;143:1224-9.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000118&pid=S0365-0596200600020000400025&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana" size="2">26. Marcil I, Stern RS. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer. A critical review of the literature and meta-analysis. Arch  Dermatol. 2000;136:1524-30.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000119&pid=S0365-0596200600020000400026&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana" size="2">27. McCormack CJ, Kelly JW, Dorevitch AP. Differences in age and body site distribution of the histological subtypes of basal cell carcinoma. Arch Dermatol. 1997;133:593-6.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000120&pid=S0365-0596200600020000400027&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana" size="2">28. Scrivener Y, Grosshans E, Cribier B. Variations of basal cell carcinomas according to gender, age, location and histopathological subtype. Br J Dermatol. 2002;147:41-7.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000121&pid=S0365-0596200600020000400028&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana" size="2">29. Rassner G, Schlagenhauff B, Breuninger H. Der klinische variantenreichtum der basaliome und seine bedeutung. In: Petres J, Lohrisch I, editors. Das basaliom: klinik und therapie. Berlim: Springer-Verlag; 1993. p.3-11.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000122&pid=S0365-0596200600020000400029&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana" size="2">30. Kopke LFF, Schmidt SM. Carcinoma basocelular. An Bras Dermatol. 2002;77:249-82.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000123&pid=S0365-0596200600020000400030&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><p>&nbsp;</p>               <p>&nbsp;</p>               <p><font face="Verdana" size="2"><a name="end"></a><a href="#topo"><img src="/img/revistas/abd/v81n2/seta.gif"  border="0"></a>    <b>Endere&ccedil;o para correspond&ecirc;ncia </b>         <br>S&ocirc;nia Antunes Oliveira Mantese                <br>Av. Par&aacute;, 1979, Bairro Umuarama           <br>38405-320 – Uberl&acirc;ndia - MG       <br>E-mail: <a href="mailto:dermato@hc.com.br">dermato@hc.com.br</a>    </font></p>               <p><font face="Verdana" size="2">Recebido em 16.12.2005.                 <br> Aprovado pelo Conselho Consultivo e aceito para publica&ccedil;&atilde;o em 20.02.2006.      ]]></body>
<body><![CDATA[<br> Conflito de interesse declarado: Nenhum  </font></p>               <p>&nbsp;</p>               <p>&nbsp;</p>               <p><font face="Verdana" size="2"><a name="nota"></a><a href="#topo">*</a> Trabalho    realizado no Servi&ccedil;o de Dermatologia do Hospital de Cl&iacute;nicas da    Universidade Federal de Uberl&acirc;ndia – HC/UFU- Uberl&acirc;ndia (MG), Brasil.    </font></p>       ]]></body><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carucci]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Leffell]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Basal cell carcinoma]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Freedberg]]></surname>
<given-names><![CDATA[IM]]></given-names>
</name>
<name>
<surname><![CDATA[Eisen]]></surname>
<given-names><![CDATA[AZ]]></given-names>
</name>
<name>
<surname><![CDATA[Wolff]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Austen]]></surname>
<given-names><![CDATA[KF]]></given-names>
</name>
<name>
<surname><![CDATA[Goldsmith]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
<name>
<surname><![CDATA[Katz]]></surname>
<given-names><![CDATA[SI]]></given-names>
</name>
</person-group>
<source><![CDATA[Fitzpatrick’s dermatology in general medicine]]></source>
<year>2003</year>
<page-range>747-54</page-range><publisher-name><![CDATA[McGraw-Hill]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Naldi]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Dilandro]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[D’Avanzo]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Parazzini]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Oncology cooperative group of the Italian group for epidemiological research in dermatology: Host-related and environmental risk factors for cutaneous basal cell carcinoma: Evidence from an Italian case-control study]]></article-title>
<source><![CDATA[J Am Acad Dermatol.]]></source>
<year>2000</year>
<volume>42</volume>
<page-range>446-52</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bastiaens]]></surname>
<given-names><![CDATA[MT]]></given-names>
</name>
<name>
<surname><![CDATA[Hoefnagel]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
<name>
<surname><![CDATA[Bruijn]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Westendorp]]></surname>
<given-names><![CDATA[RGJ]]></given-names>
</name>
<name>
<surname><![CDATA[Bavinck]]></surname>
<given-names><![CDATA[VNB]]></given-names>
</name>
<name>
<surname><![CDATA[Bavinck]]></surname>
<given-names><![CDATA[JNB]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Differences in age, site distribution, and sex between nodular and superficial basal cell carcinomas indicate different types of tumors]]></article-title>
<source><![CDATA[J Invest Dermatol]]></source>
<year>1998</year>
<volume>110</volume>
<page-range>880-4</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Katz]]></surname>
<given-names><![CDATA[M.H.]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Nonmelanoma skin cancer]]></article-title>
<source><![CDATA[Maryl Med J.]]></source>
<year>1997</year>
<volume>46</volume>
<page-range>238-42</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Maafs]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[De La Barreda]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Delgado]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Mohar]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Alfeirán]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Basal cell carcinoma of trunk and extremities]]></article-title>
<source><![CDATA[Int J Dermatol.]]></source>
<year>1997</year>
<volume>36</volume>
<page-range>622-8</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Franceschi]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Levi]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Randimbison]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[La Vecchia]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Site distribution of different types of skin cancer: new aetiological clues]]></article-title>
<source><![CDATA[Int J Cancer]]></source>
<year>1996</year>
<volume>67</volume>
<page-range>24-8</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Corona]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Epidemiology of nonmelanoma skin cancer: review]]></article-title>
<source><![CDATA[Ann Ist Super Sanità]]></source>
<year>1996</year>
<volume>32</volume>
<page-range>37-42</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Green]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Battistutta]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Hart]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Leslie]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Weedon]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Nambour Study Group: Skin cancer in a subtropical Australian population: incidence and lack of association with occupation]]></article-title>
<source><![CDATA[Am J Epidemiol]]></source>
<year>1996</year>
<volume>144</volume>
<page-range>1034-40</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Castro]]></surname>
<given-names><![CDATA[LGM]]></given-names>
</name>
<name>
<surname><![CDATA[Toyana]]></surname>
<given-names><![CDATA[CL]]></given-names>
</name>
<name>
<surname><![CDATA[Gomes]]></surname>
<given-names><![CDATA[AP]]></given-names>
</name>
<name>
<surname><![CDATA[Freire]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Britto]]></surname>
<given-names><![CDATA[TF]]></given-names>
</name>
</person-group>
<article-title xml:lang="pt"><![CDATA[Câncer de pele em clínica particular em São Paulo - SP]]></article-title>
<source><![CDATA[An Bras Dermatol]]></source>
<year>1996</year>
<volume>71</volume>
<page-range>471-6</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Maia]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Proença]]></surname>
<given-names><![CDATA[NG]]></given-names>
</name>
<name>
<surname><![CDATA[Moraes]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Risk factors for basal cell carcinoma: a case-control study]]></article-title>
<source><![CDATA[Rev Saude Publica]]></source>
<year>1995</year>
<volume>29</volume>
<page-range>27-37</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bandeira]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Bandeira]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[JF]]></given-names>
</name>
<name>
<surname><![CDATA[Mazza]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang="pt"><![CDATA[Carcinoma basocelular: estudo clínico e anatomopatológico de 704 tumores]]></article-title>
<source><![CDATA[An Bras Dermatol]]></source>
<year>2003</year>
<volume>78</volume>
<page-range>23-34</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Betti]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Inselvini]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Carducci]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Crosti]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Age and site prevalence of histologic subtypes of basal cell carcinomas]]></article-title>
<source><![CDATA[Int J Dermatol]]></source>
<year>1995</year>
<volume>34</volume>
<page-range>174-6</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Machado Filho]]></surname>
<given-names><![CDATA[CDA]]></given-names>
</name>
<name>
<surname><![CDATA[Fagundes]]></surname>
<given-names><![CDATA[DS]]></given-names>
</name>
<name>
<surname><![CDATA[Sender]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Saraiva]]></surname>
<given-names><![CDATA[GL]]></given-names>
</name>
<name>
<surname><![CDATA[Paschoal]]></surname>
<given-names><![CDATA[LHC]]></given-names>
</name>
<name>
<surname><![CDATA[Costa]]></surname>
<given-names><![CDATA[MCC]]></given-names>
</name>
</person-group>
<article-title xml:lang="pt"><![CDATA[Neoplasias malignas cutâneas: estudo epidemiológico]]></article-title>
<source><![CDATA[An Bras Dermatol.]]></source>
<year>1996</year>
<volume>71</volume>
<page-range>479-84</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Prado]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang="pt"><![CDATA[Carcinoma basocelular]]></article-title>
<source><![CDATA[An Bras Dermatol.]]></source>
<year>1987</year>
<volume>62</volume>
<page-range>143-6</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[English]]></surname>
<given-names><![CDATA[DR]]></given-names>
</name>
<name>
<surname><![CDATA[Armstrong]]></surname>
<given-names><![CDATA[BK]]></given-names>
</name>
<name>
<surname><![CDATA[Kricker]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Fleming]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Sunlight and cancer]]></article-title>
<source><![CDATA[Cancer Causes Control]]></source>
<year>1997</year>
<volume>8</volume>
<page-range>271-83</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Saldanha]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[The Hedgehog signaling pathway and cancer]]></article-title>
<source><![CDATA[J Pathol]]></source>
<year>2001</year>
<volume>193</volume>
<page-range>427-32</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bale]]></surname>
<given-names><![CDATA[AE]]></given-names>
</name>
<name>
<surname><![CDATA[Yu]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[The Hedgehog pathway and basal cell carcinomas]]></article-title>
<source><![CDATA[Hum Mol Genet.]]></source>
<year>2001</year>
<volume>10</volume>
<page-range>757-62</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fitzpatrick]]></surname>
<given-names><![CDATA[TB]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[The validity and practicality of sun reactive skin types I-VI]]></article-title>
<source><![CDATA[Arch Dermatol]]></source>
<year>1988</year>
<volume>124</volume>
<page-range>869-71</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Odom]]></surname>
<given-names><![CDATA[RB]]></given-names>
</name>
<name>
<surname><![CDATA[James]]></surname>
<given-names><![CDATA[WD]]></given-names>
</name>
<name>
<surname><![CDATA[Berger]]></surname>
<given-names><![CDATA[TG]]></given-names>
</name>
</person-group>
<source><![CDATA[Andrew’s diseases of the skin: clinical dermatology]]></source>
<year>2000</year>
<edition>9th</edition>
<page-range>800-68</page-range><publisher-loc><![CDATA[Philadelphia ]]></publisher-loc>
<publisher-name><![CDATA[W.B. Saunders]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rippey]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Why classify basal cell carcinomas?]]></article-title>
<source><![CDATA[Histopathology]]></source>
<year>1998</year>
<volume>32</volume>
<page-range>393-8</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kirkham]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Tumors and cysts of the epidermis]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Elder]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Elenitsas]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Jaworsky]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Johnson]]></surname>
<given-names><![CDATA[Jr]]></given-names>
</name>
</person-group>
<source><![CDATA[Lever’s histopathology of the skin]]></source>
<year>1997</year>
<page-range>685-746</page-range><publisher-loc><![CDATA[Philadelphia ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[McKie]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Epidermal skin tumors]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Champion]]></surname>
<given-names><![CDATA[RH]]></given-names>
</name>
<name>
<surname><![CDATA[Burton]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Burns]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
<name>
<surname><![CDATA[Breathnach]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
</person-group>
<source><![CDATA[Rook/Wilkinson/Ebling: textbook of dermatology]]></source>
<year>2004</year>
<page-range>1651-93</page-range><publisher-loc><![CDATA[London ]]></publisher-loc>
<publisher-name><![CDATA[Blackwell Science]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Minelli]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang="pt"><![CDATA[Estudo estatístico do carcinoma basocelular em Londrina, Paraná, Brasil]]></article-title>
<source><![CDATA[An Bras Dermatol]]></source>
<year>1987</year>
<volume>62</volume>
<page-range>321-5</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dahl]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Aberg]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Rausing]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Rausing]]></surname>
<given-names><![CDATA[EL]]></given-names>
</name>
</person-group>
<article-title xml:lang="pt"><![CDATA[Basal cell carcinoma]]></article-title>
<source><![CDATA[Cancer]]></source>
<year>1992</year>
<volume>70</volume>
<page-range>104-8</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Holme]]></surname>
<given-names><![CDATA[AS]]></given-names>
</name>
<name>
<surname><![CDATA[Malinovszky]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Roberts]]></surname>
<given-names><![CDATA[DL]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Changing trends in non-melanoma skin cancer in South Wales, 1988-98]]></article-title>
<source><![CDATA[Br J Dermatol]]></source>
<year>2000</year>
<volume>143</volume>
<page-range>1224-9</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Marcil]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Stern]]></surname>
<given-names><![CDATA[RS]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: A critical review of the literature and meta-analysis]]></article-title>
<source><![CDATA[Arch Dermatol]]></source>
<year>2000</year>
<volume>136</volume>
<page-range>1524-30</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[McCormack]]></surname>
<given-names><![CDATA[CJ]]></given-names>
</name>
<name>
<surname><![CDATA[Kelly]]></surname>
<given-names><![CDATA[JW]]></given-names>
</name>
<name>
<surname><![CDATA[Dorevitch]]></surname>
<given-names><![CDATA[AP]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Differences in age and body site distribution of the histological subtypes of basal cell carcinoma]]></article-title>
<source><![CDATA[Arch Dermatol]]></source>
<year>1997</year>
<volume>133</volume>
<page-range>593-6</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Scrivener]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Grosshans]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Cribier]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Variations of basal cell carcinomas according to gender, age, location and histopathological subtype]]></article-title>
<source><![CDATA[Br J Dermatol]]></source>
<year>2002</year>
<volume>147</volume>
<page-range>41-7</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rassner]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Schlagenhauff]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Breuninger]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang="de"><![CDATA[Der klinische variantenreichtum der basaliome und seine bedeutung]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Petres]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Lohrisch]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<source><![CDATA[Das basaliom: klinik und therapie]]></source>
<year>1993</year>
<page-range>3-11</page-range><publisher-loc><![CDATA[Berlim ]]></publisher-loc>
<publisher-name><![CDATA[Springer-Verlag]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kopke]]></surname>
<given-names><![CDATA[LFF]]></given-names>
</name>
<name>
<surname><![CDATA[Schmidt]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
</person-group>
<article-title xml:lang="pt"><![CDATA[Carcinoma basocelular]]></article-title>
<source><![CDATA[An Bras Dermatol]]></source>
<year>2002</year>
<volume>77</volume>
<page-range>249-82</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
